THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE(-/-) mice

Remco A. Haasdijk, Wijnand K. Den Dekker, Caroline Cheng, Dennie Tempel, Robert Szulcek, Frank L. Bos, Dorien M. A. Hermkens, Ihsan Chrifi, Maarten M. Brandt, Chris Van Dijk, Yan Juan Xu, Esther H. M. Van De Kamp, Lau A. J. Blonden, Jan Van Bezu, Judith C. Sluimer, Erik A. L. Biessen, Geerten P. Van Nieuw Amerongen, Henricus J. Duckers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

26 Downloads (Pure)


Impairment of the endothelial barrier leads to microvascular breakdown in cardiovascular disease and is involved in intraplaque haemorrhaging and the progression of advanced atherosclerotic lesions that are vulnerable to rupture. The exact mechanism that regulates vascular integrity requires further definition. Using a microarray screen for angiogenesis-associated genes during murine embryogenesis, we identified thrombospondin type I domain 1 (THSD1) as a new putative angiopotent factor with unknown biological function. We sought to characterize the role of THSD1 in endothelial cells during vascular development and cardiovascular disease. Functional knockdown of Thsd1 in zebrafish embryos and in a murine retina vascularization model induced severe haemorrhaging without affecting neovascular growth. In human carotid endarterectomy specimens, THSD1 expression by endothelial cells was detected in advanced atherosclerotic lesions with intraplaque haemorrhaging, but was absent in stable lesions, implying involvement of THSD1 in neovascular bleeding. In vitro, stimulation with pro-atherogenic factors (3% O-2 and TNF alpha) decreased THSD1 expression in human endothelial cells, whereas stimulation with an anti-atherogenic factor (IL10) showed opposite effect. Therapeutic evaluation in a murine advanced atherosclerosis model showed that Thsd1 overexpression decreased plaque vulnerability by attenuating intraplaque vascular leakage, subsequently reducing macrophage accumulation and necrotic core size. Mechanistic studies in human endothelial cells demonstrated that THSD1 activates FAK-PI3K, leading to Rac1-mediated actin cytoskeleton regulation of adherens junctions and focal adhesion assembly. THSD1 is a new regulator of endothelial barrier function during vascular development and protects intraplaque microvessels against haemorrhaging in advanced atherosclerotic lesions.
Original languageEnglish
Pages (from-to)129-139
JournalCardiovascular Research
Issue number1
Publication statusPublished - 1 May 2016


  • Vulnerable plaque
  • Intraplaque haemorrhage
  • Endothelial function
  • THSD1

Cite this